Breast Reconstruction Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Breast Reconstruction Market Analysis
The breast reconstruction market is projected to register a CAGR of 7.1% over the forecast period.
The COVID-19 pandemic had a short-term impact on the breast implant market, primarily during the initial phase of the pandemic. Due to restrictions and lockdown, the ongoing and scheduled surgical procedures were delayed or canceled, hindering the growth of the breast implant market. However, the interest and growing awareness regarding physical appearance increased during the COVID-19 pandemic among women in the United States, including breast implants and augmentation. For instance, according to the April 2021 survey report by the ASPS, 11% of the surveyed women were more inclined toward cosmetic surgery or non-surgical procedures than before the pandemic. Therefore, the market is expected to recover soon from the impact of the COVID-19 pandemic and is expected to grow.
The major factor driving the growth of the market studied is the increasing incidence of breast cancer. According to GLOBOCAN 2020, breast cancer surpassed lung cancer and became the most diagnosed cancer worldwide. According to the WHO, in 2020, around 2.3 million women were diagnosed with breast cancer globally. About 7.8 million women have been diagnosed with breast cancer over the last five years. In Asian women, breast cancer prevalence was high, accounting for 22.9% of the total cancer cases in women in 2020. Increasing awareness about the safety of breast reconstruction options is reassuring women undergoing mastectomy and other breast cancer surgeries to choose the reconstruction process.
The increasing products of innovative products are boosting the market's growth. For instance, in October 2020, GC Aesthetics launched Perle, a novel round breast implant. It is developed with reverse surface technology allowing for reduced inflammation and easier placement and incision. Such introduction of advanced breast implants is expected to contribute to the growth of the market.
Thus, factors such as the increasing incidence of breast cancer, increasing awareness among the global population, and innovative product launches are expected to drive the growth of the market studied. However, the high cost of breast reconstruction procedures is the major factor restraining the growth of the market.
Breast Reconstruction Market Trends
This section covers the major market trends shaping the Breast Reconstruction Market according to our research experts:
Breast Implants Holds the Largest Share in the Breast Reconstruction Market Over the Forecast Period
The usage of breast implants in breast reconstruction surgeries accounted for a significant share of the global market, and this is expected to remain a prominent trend in the breast reconstruction market in the forecast period.
Increasing awareness and inclination among women across the world toward breast augmentation and reconstruction procedures for beauty enhancement is another factor expected to boost the growth of the market studied. According to the 2020 International Society for Aesthetic Plastic Surgeons (ISAPS) statistics, there were about 193,073 breast augmentation procedures in the United States in 2020, which was more than any other performed aesthetic surgery.
The market players in the area are continuously working toward better and more efficient solutions and evolving the life of available products through new product launches, collaborations, and mergers and acquisitions, which will also complement the growth of the breast implant segment. For instance, in May 2021, GC Aesthetics Inc. launched a next-generation breast implant called PERLE, a smooth breast implant with a proprietary surface technology called BioQ.
Thus, considering all the above-mentioned factors, such as increasing awareness and inclination among women worldwide toward breast augmentation and reconstruction procedures and new product launches, the segment studied is expected to witness high growth over the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America is expected to dominate the market studied during the forecast period due to the high incidence of breast cancer, increasing breast augmentation procedures, and established healthcare infrastructure.
For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures in 2020 in the United States. The increasing prevalence of breast cancer in this region is anticipated to boost the growth of the breast implant market in the region. According to the GLOBOCAN 2020 report, the new breast cancer cases in the United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period. Beneficial government initiatives and increased research partnerships are expected to drive the market's growth.
The rising product approvals are expected to contribute to the growth of the market in this region. For instance, in March 2022, Sientra Inc. received approval from Health Canada to market the company's line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in Canada. The rising prevalence of breast cancer and the increasing focus of market players in this region are expected to boost the growth of the breast reconstruction market in North America.
Breast Reconstruction Industry Overview
The breast reconstruction market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra Inc., Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs SA, POLYTECH Health & Aesthetics GmbH, RTI Surgical Inc., Groupe Sebbin SAS, Integra LifeSciences, GC Aesthetics.
Breast Reconstruction Market Leaders
-
Allergan Plc
-
Johnson & Johnson
-
Establishment Labs S.A.
-
Sientra, Inc
-
Ideal Implant Incorporated
*Disclaimer: Major Players sorted in no particular order
Breast Reconstruction Market News
- In June 2022, Coll Plant announced the initiation of a study in large animals for its 3D bioprinted regenerative breast implant program, addressing the demands of breast reconstruction.
- In May 2022, GC Aesthetics launched the Innovative Areola Complex (NAC) reconstruction implant, FixNip NRI. This medical device is the answer to a well-known clinical need of thousands of women around the world.
Breast Reconstruction Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Incidence of Breast Cancer
- 4.2.2 Introduction of Technologically Advanced Products
-
4.3 Market Restraints
- 4.3.1 High Cost of Breast Reconstruction Procedures
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Breast Implants
- 5.1.2 Tissue Expanders
- 5.1.3 Acellular Dermal Matrices
- 5.1.4 Other Products
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Ambulatory Care Centers
- 5.2.3 Other End Users
-
5.3 By Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Allergan PLC
- 6.1.2 Sientra Inc.
- 6.1.3 Ideal Implant Incorporated
- 6.1.4 Johnson & Johnson
- 6.1.5 Establishment Labs SA
- 6.1.6 Polytech Health & Aesthetics GmbH
- 6.1.7 RTI Surgical Inc.
- 6.1.8 Groupe Sebbin SAS
- 6.1.9 Integra LifeSciences
- 6.1.10 GC Aesthetics
- 6.1.11 Sebbin
- 6.1.12 Silimed
- 6.1.13 Laboratories Arion
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityBreast Reconstruction Industry Segmentation
As per the scope of the report, breast reconstruction is a surgical procedure that restores shape to your breast after surgery that removes your breast to treat or prevent breast cancer.
The breast reconstruction market is segmented by product (breast implants, tissue expanders, acellular dermal matrices, and other products), end user (hospitals, ambulatory care centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product | Breast Implants | |
| Tissue Expanders | ||
| Acellular Dermal Matrices | ||
| Other Products | ||
| By End User | Hospitals | |
| Ambulatory Care Centers | ||
| Other End Users | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Breast Reconstruction Market Research FAQs
What is the current Breast Reconstruction Market size?
The Breast Reconstruction Market is projected to register a CAGR of 7.10% during the forecast period (2024-2029)
Who are the key players in Breast Reconstruction Market?
Allergan Plc, Johnson & Johnson, Establishment Labs S.A., Sientra, Inc and Ideal Implant Incorporated are the major companies operating in the Breast Reconstruction Market.
Which is the fastest growing region in Breast Reconstruction Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Breast Reconstruction Market?
In 2024, the North America accounts for the largest market share in Breast Reconstruction Market.
What years does this Breast Reconstruction Market cover?
The report covers the Breast Reconstruction Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Breast Reconstruction Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Breast Reconstruction Industry Report
Statistics for the 2024 Breast Reconstruction market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Breast Reconstruction analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
